Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 12;22(1):48.
doi: 10.1186/s12967-024-04860-1.

Single-cell sequencing reveals the heterogeneity of B cells and tertiary lymphoid structures in muscle-invasive bladder cancer

Affiliations

Single-cell sequencing reveals the heterogeneity of B cells and tertiary lymphoid structures in muscle-invasive bladder cancer

Hao Yuan et al. J Transl Med. .

Abstract

Background: Muscle-invasive bladder cancer (MIBC) is a highly aggressive disease with a poor prognosis. B cells are crucial factors in tumor suppression, and tertiary lymphoid structures (TLSs) facilitate immune cell recruitment to the tumor microenvironment (TME). However, the function and mechanisms of tumor-infiltrating B cells and TLSs in MIBC need to be explored further.

Methods: We performed single-cell RNA sequencing analysis of 11,612 B cells and 55,392 T cells from 12 bladder cancer patients and found naïve B cells, proliferating B cells, plasma cells, interferon-stimulated B cells and germinal center-associated B cells, and described the phenotype, gene enrichment, cell-cell communication, biological processes. We utilized immunohistochemistry (IHC) and immunofluorescence (IF) to describe TLSs morphology in MIBC.

Results: The interferon-stimulated B-cell subtype (B-ISG15) and germinal center-associated B-cell subtypes (B-LMO2, B-STMN1) were significantly enriched in MIBC. TLSs in MIBC exhibited a distinct follicular structure characterized by a central region of B cells resembling a germinal center surrounded by T cells. CellChat analysis showed that CXCL13 + T cells play a pivotal role in recruiting CXCR5 + B cells. Cell migration experiments demonstrated the chemoattraction of CXCL13 toward CXCR5 + B cells. Importantly, the infiltration of the interferon-stimulated B-cell subtype and the presence of TLSs correlated with a more favorable prognosis in MIBC.

Conclusions: The study revealed the heterogeneity of B-cell subtypes in MIBC and suggests a pivotal role of TLSs in MIBC outcomes. Our study provides novel insights that contribute to the precision treatment of MIBC.

Keywords: B cells; CXCL13; Muscle-invasive bladder cancer; Single-cell sequencing; Tertiary lymphoid structures.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Single-cell transcriptional profiles of bladder cancer tissues and adjacent lymph nodes. A Schematic of the workflow. B The t-distributed stochastic neighbor embedding (tSNE) plot displays the cellular profiles of individual cells, which have been characterized by their dominant cell types. C tSNE plot of single cells profiled by dominant cell types (B cells). D Box plot showing the proportion of B cells and plasma cells from MIBC, NMIBC, normal tissue, PBMC, and lymph node samples. MIBC, n = 7; NMIBC, n = 3; Normal, n = 9; PBMC, n = 4; lymph nodes, n = 3. E, F Immunohistochemical staining of CD19 showing B-cell infiltration in tumor (left), normal tissue, and lymph node (right) samples. Scale bar: 2.5 mm in panoramic images and 250 μm in magnified images
Fig. 2
Fig. 2
B cells in MIBC. A tSNE plot showing the subclustering of 11,612 B cells from 12 patients with bladder cancer. Each cluster is shown in a different color. Twelve clusters are shown in each plot. B The tSNE map shows the distribution of B-cell characteristic genes CD79A and MS4A1 and plasma cell characteristic genes IGHA1 and MZB1. C Heatmap showing the expression levels of functional markers of B-cell subtypes
Fig. 3
Fig. 3
Interferon-stimulated B cells are enriched in MIBC. A tSNE plots of B cells in MIBC; n = 7; NMIBC, n = 3; normal, n = 9; PBMC, n = 4; lymph nodes, n = 3. Each cluster is shown in a different color. B The bar plots depict the mean cell count of each B-cell subtype in each sample on the left. In the middle, the bar plots illustrate the proportion of each B-cell subtype in each sample. On the right, a box plot displays the proportion of B-ISG15 in each sample.; MIBC, n = 7; NMIBC, n = 3; Normal, n = 9; PBMC, n = 4; lymph nodes, n = 3. C Heatmap shows the GSEA score of a set of hallmark genes enriched in B-cell subtypes. D Heatmap showing the activity of SCENIC transcription factor regulons in each B-cell subtype. E Expression levels of STAT1 and IRF9 marker genes illustrated in tSNE plots in each B-cell subtype. F The violin plots depict the expression patterns of IFN-γ genes, colors as in (A)
Fig. 4
Fig. 4
Germinal center-associated B-cell subtypes present in MIBC. A Heatmap shows GSVA scores of enriched germinal center-associated gene sets. B tSNE plot showing the expression densities of the LMO2, AICDA, and NEIL1 genes in B-cell subtypes. C The Gene Ontology (GO) terms of genes that exhibited significant enrichment in B-LMO2 (top) and B-STMN1 (bottom) were determined through the application of Fisher's test for statistical analysis. D RNA velocity of B-cell subtypes. It shows the transformation of B-cell subtypes. E Box plot showing the proportions of B-LMO2 (left) and B-STMN1 (right) in MIBC, NMIBC, normal tissue, PBMC, and lymph node samples
Fig. 5
Fig. 5
TLSs in MIBC. A HE staining shows TLSs (red squares) in MIBC, and IHC staining shows the following markers of TLSs (red squares): CD45, CD19, CD3, MKI67, CD4, CD8, PD-1, CD21, LAMP3, MECA79A and LMO2. Scale bar: 2.5 mm in panoramic images and 100 μm in magnified images. B H&E staining and IHC for the indicated markers for representative LNs (two columns below) and TLSs (two columns above). Scale bar: 2.5 mm in panoramic images and 100 μm in magnified images. C mIF for the indicated markers for representative TLSs. The following markers are shown in individual and merged channels: CD3 (green), T-cell marker; CD19 (red), B-cell marker; DAPI (blue), nuclear marker. Scale bar: 25 μm
Fig. 6
Fig. 6
Transcriptome analysis revealed that T cells recruit B cells via CXCL13-CXCR5 in MIBC. A tSNE plot showing T-cell subtypes. B Average cell numbers of T-cell subtypes in original samples (left). Box plot showing the proportions of CD8_Tex (middle) and CD4_Tex (right) cells in the original samples. C Heatmap indicating the scaled expression of T-cell marker genes. D Bubble plot indicating cell roles: The color of the dots represents different cell groups, the size of the dots is proportional to the number of ligands and receptors inferred for each cell group, and the x and y axes indicate the strength of the cell group as a signal sender and receiver, respectively. E Hierarchy diagram: “Source” represents the cell class that sends the signal, “target” represents the cell class that receives the signal, and the circle color represents the cell class. F The signaling pathway relationship to the bubble diagram shows significant interactions between the ligand‒receptor (L-R) pairs of subpopulations. G The violin diagram shows the expression levels of genes involved in signaling pathways. H Migration of CXCR5 + B cells treated with (middle) or without (left) CXCL13 and the CXCR5 antagonist (right)
Fig. 7
Fig. 7
Prognostic value of B-cell subtypes and TLSs in MIBC. A The Kaplan‒Meier method was used to analyze the effect of different B-cell subtypes on the survival rate of patients with MIBC (p < 0.05). B The Kaplan‒Meier method was used to analyze the effect of MS4A1 (CD20), CD3d, LMO2, AICDA and NEIL1 gene combination expression on the survival rate of patients with MIBC (p < 0.05)

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Tran LD, Xiao JF, Agarwal N, Duex JE, Theodorescu D. Advances in bladder cancer biology and therapy. Nat Rev Cancer. 2021;21:104–121. doi: 10.1038/s41568-020-00313-1. - DOI - PMC - PubMed
    1. Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo GW, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell. 2017;174:1033. doi: 10.1016/j.cell.2018.07.036. - DOI - PMC - PubMed
    1. Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, Lotan Y. Bladder cancer. Nat Rev Dis Primers. 2017;3:17022. doi: 10.1038/nrdp.2017.22. - DOI - PubMed
    1. Anderson NM, Simon MC. The tumor microenvironment. Curr Biol. 2020;30:R921–R925. doi: 10.1016/j.cub.2020.06.081. - DOI - PMC - PubMed

Publication types